Αποτελέσματα Αναζήτησης
1 Απρ 2020 · This review gives an overview of recent developments in immunotherapy and indicates a new direction of tumor treatment through analyzing the pros and cons of immunotherapy coupled with keeping a close watch on the development trend of the immunotherapy future.
- Conditioning Neoadjuvant Therapies for Improved Immunotherapy of Cancer
Rescovitine is not toxic for tumor-reactive T cells [79] and...
- Sci
Infectious complications, predominantly pulmonary and...
- Natural Killer Cells Unleashed
Cancer cells are cells undergoing unregulated cell division....
- Conditioning Neoadjuvant Therapies for Improved Immunotherapy of Cancer
21 Φεβ 2023 · Different tumor-specific vaccination strategies are gaining ground in the treatment of lung cancer. Recent advances in adoptive cell therapy (CAR T, TCR, TIL), the associated clinical trials on lung cancer, and associated hurdles are discussed in this review.
13 Σεπ 2023 · The three main types of immunotherapy for lung cancer are checkpoint inhibitors, cancer vaccines, and CAR T-cell therapy. Only checkpoint inhibitors immunotherapy is FDA-approved for use on lung cancers.
13 Μαΐ 2021 · This article will review the landmark studies that have led to U.S. Food and Drug Administration (FDA) approval of single-agent immunotherapy, combination immunotherapy (i.e., dual immunotherapy), and immunotherapy in conjunction with chemotherapy for the treatment of patients with advanced NSCLC.
Immunotherapy undeniably plays an important part in cancer treatment—contributing to a future that transforms cancer from an acute diagnosis to a chronic manageable disease. But no anticancer treatment comes without risk.
1 Απρ 2020 · In this review article, we highlight the current standards of care in cancer immunotherapy, with a strong focus on immune checkpoint inhibitors (ici s), their limitations and pitfalls, and promising novel approaches.
15 Δεκ 2020 · It may facilitate immune cells to win the battle against cancerous cells by hampering the growth process of cancer cells or inhibiting the blood vessels to help in providing nutrition to the tumor cells.
